HCTI Stock Analysis: Buy, Sell, or Hold?
HCTI - Healthcare Triangle, Inc. Common Stock
$1.10
-0.04 (-3.93%)
βΌ
5d:
-32.1%
30d:
-43.3%
90d:
-51.54%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 13, 2026
9d
Get Alerted When HCTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: HCTI is down 32.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: HCTI is down 32.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: HCTI is currently trading at $1.10, which is considered oversold relative to its 30-day fair value range of $1.54 to $1.96.
Technical Outlook: Technically, HCTI is in a strong downtrend. The price is currently testing key support at $1.09. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+354.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HCTI is in a strong downtrend. The price is currently testing key support at $1.09. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+354.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.54 -
$1.96
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BULLISH: Trading 354.5% below Wall St target ($5.00)
- WARNING: Recommendation downgraded due to -32.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.54 -
$1.96
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.09
Resistance Level
$1.82
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.11
Wall Street Target
$5.00
(+354.5%)
Revenue Growth (YoY)
166.1%
Profit Margin
-69.7%
Share & Embed Analysis
Last updated: August 03, 2026 12:31 AM ET
Data refreshes hourly during market hours. Next update: 1:31 AM
Data refreshes hourly during market hours. Next update: 1:31 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HCTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 59 HOLD |
|
GEHC
GE HealthCare Technologi⦠|
STRONG BUY
21 analysts |
$90 | 53 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 49 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 50 HOLD |